Sumamry
We have previously reported from a cross-sectional study that plasma total cholesterol, triglycerides, and HDL-C were significantly and independently correlated with Na+−Li+ countertransport. These original participants were rescreened 2 1/2 years later (range of 20–58 months), with lipid, blood pressure, and Na+−Li+ countertransport measurements from both visits on 906 normotensive adults. The correlation found between age-and sex-adjusted triglyceride levels and Na+−Li+ countertransport at visit 1 (r=0.34, p<0.0001) was reconfirmed at visit 2 (r=0.32, p<0.0001). The Na+−Li+ countertransport correlations with HDL-C (r=−0.11, p<0.01) and body mass index (r=0.24, p<0.0001) also remained at visit 2. After 30 months, there were significant increases of triglyceride, body mass index, blood pressure, and Na+−Li+ countertransport levels, and significant decreases of HDL-C and total cholesterol levels, after adjusting the changes in these variables between visit 2 and visit 1 for age, sex, time between the two visits, and the visit 1 level of the variable. Increases in triglycerides, cholesterol, and body mass index were significantly correlated with increases in Na+−Li+ countertransport (r=0.23, r=0.19, and r=0.21, respectively). The correlations of the lipid and lipoprotein changes with Na+−Li+ countertransport changes were independent of body mass index and blood pressure changes. We conclude that increasing plasma triglyceride levels and body mass index are associated with increasing Na+−Li+ countertransport levels in both cross-sectional and longitudinal data.
Similar content being viewed by others
References
Canessa M, Adragna N, Solomon HS, et al. Increased sodium-lithium countertransport in red cells of patients with essential hypertension.N Engl J Med 1980;302:772–776.
Williams RR, Hunt SC, Kuida H, et al. Sodium-lithium countertransport in erythrocytes of hypertension prone families in Utah.Am J Epidemiol 1983;118:338–344.
Hunt SC, Williams RR, Smith JB, et al. Associations of three erythrocyte cation transport systems with plasma lipids in Utah subjects.Hypertension 1986;8:30–36.
Canessa M, Morgan K, Semplicini A. Genetic differences in lithium-sodium exchange and regulation of the sodium-hydrogen exchanger in essential hypertension.J Cardiovasc Pharmacol 1988;12:S92-S98.
Hasstedt SJ, Wu LL, Ash KO, et al. Hypertension and sodium-lithium countertransport in Utah pedigrees: Evidence for major-locus inheritance.Am J Hum Genet 1988;43:14–22.
Boerwinkle E, Turner ST, Weinshilboum R, et al. Analysis of the distribution of erythrocyte sodium lithium countertransport in a sample representative of the general population.Genet Epidemiol 1986;3:365–378.
Cooper R, LeGrady D, Nanas S, et al. Increased sodium-lithium countertransport in college students with elevated blood pressure.JAMA 1983;249:1030–1034.
Weder AB, Torretti BA, Julius S. Racial differences in erythrocyte cation transport.Hypertension 1984;6:115–123.
Tuck ML, Gross C, Maxwell MH, et al. Erythrocyte Na+, K+ cotransport and Na+, K+ pump in black and Caucasion hypertensive patients.Hypertension 1984;6:536–544.
Trevisan M, Ostrow D, Cooper R, et al. Abnormal red blood cell ion transport and hypertension: The people's gas company study.Hypertension 1983;5:363–367.
Worley RJ, Hentschel WM, Cormier C, et al. Increased sodium-lithium countertransport in erythrocytes of pregnant women.N Engl J Med 1982;307:412–416.
Adragna NC, Chang JL, Morey MC, Williams RS. Effect of exercise on cation transport in human red cells.Hypertension 1985;7:132–139.
Williams RR, Hunt SC. Recruitment of members of high-risk Utah pedigrees.Controlled Clin Trials 1987;8:105S-114S.
Levine JB, Zak B. Automated determination of serum total cholesterol.Clin Chim Acta 1964;10:381–384.
Wahlefeld AW. Triglycerides: Determination after enzymatic hydrolysis. In: Bergmeyer HU, ed.Methods of enzymatic analysis, Vol 4, New York: Academic Press, 1974: 1831–1835.
Warnick GR, Cheung MC, Albers JJ. Comparison of current methods for high density lipoprotein cholesterol quantitation.Clin Chem 1979;25:596–604.
Warnick GR, Benderson JM, Albers JJ. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density lipoprotein cholesterol.Clin Chem 1982;28:1379–1388.
Smith JB, Ash KO, Hentschel WM, et al. A simplified method for simultaneously determining countertransport and cotransport in human erythrocytes.Clin Chim Acta 1984;137:169–177.
Smith JB, Price AL, Williams RR, et al. A reproducible sodium-lithium countertransport assay: The outcome of changing key laboratory parameters.Clin Chim Acta 1982;122:327–335.
Woods JW, Falk RJ, Pittman AW, et al. Increased red-cell sodium-lithium countertransport in normotensive sons of hypertensive parents.N Engl J Med 1982;306:593–595.
Canessa M, Spalvins A, Adragna N, Falkner B. Red cell sodium countertransport and cotransport in normotensive and hypertensive blacks.Hypertension 1984;6:344–351.
Hespel P, Lijnen P, Fagard R, et al. Changes in erythrocyte sodium and plasma lipids associated with physical training.J Hypertens 1988;6:159–166.
Wu LL, Hunt SC, Afman G, et al. Genetic concordance of and exercise effects on low density lipoprotein subfractions in Utah twins.Circulation 1988;78:II-480.
Wiliams PT, Krauss RM, Vranizan KM, Wood PD. Exercise-induced and diet-induced weight loss produce similar changes in lipoprotein subfraction levels.Circulation 1988;78:II-195.
McNamara JR, Compos H, Ordovas JM, et al. Effect of gender, age and lipid status on low density lipoprotein subfraction distribution: Results from the Framingham off-spring study.Arteriosclerosis 1987;7:483–490.
Austin MA, Breslow JL, Hennekens CH, et al. Low-density lipoprotein subclass patterns and risk of myocardial infarction.JAMA 1988;260:1917–1921.
Hunt SC, Wu LL, Hopkins PN, et al. Apolipoprotein, LDL subfraction, and insulin associations with familial combined hyperlipidemia in Utah patients with familial dyslipidemic hypertension.Arteriosclerosis 1989;9:335–344.
Williams RR, Hunt SG, Hopkins PN, et al. Familial dyslipidemic hypertension: Evidence from 58 Utah families for a syndrome present in approximately 15% of patients with essential hypertension.JAMA 1988;259:3579–3586.
Bing FR, Heagerty AM, Swales JD. Dietary changes in membrane lipids and leucocyte calcium.J Cardiovasc Pharmacol 1988;12:S110-S113.
Ollerenshaw JD, Heagerty AM, Bing FR, Swales JD. Abnormalities of erythrocyte membrane fatty acid composition in human essential hypertension.J Hum Hypertens 1987;1:9–12.
Sprafka JM, Folsom AR, Burke GL, Edlavitch SA. Prevalence of cardiovascular disease risk factors in blacks and whites: The Minnesota heart survey.Am J Public Health 1988;78:1546–1549.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hunt, S.C., Williams, R.R. & Ash, K.O. Changes in sodium-lithium countertransport correlate with changes in triglyceride levels and body mass index over 2 1/2 years of follow-up in utah. Cardiovasc Drug Ther 4 (Suppl 2), 357–362 (1990). https://doi.org/10.1007/BF02603176
Issue Date:
DOI: https://doi.org/10.1007/BF02603176